中华小儿外科杂志
中華小兒外科雜誌
중화소인외과잡지
CHINESE JOURNAL OF PEDIATRIC SURGERY
2008年
10期
619-623
,共5页
张树威%陈安民%游洪波%廖晖%宋登新%王江%谢柏臻%刘铁%郭风劲
張樹威%陳安民%遊洪波%廖暉%宋登新%王江%謝柏臻%劉鐵%郭風勁
장수위%진안민%유홍파%료휘%송등신%왕강%사백진%류철%곽풍경
干细胞%免疫磁化分离%甲状旁腺激素相关蛋白质
榦細胞%免疫磁化分離%甲狀徬腺激素相關蛋白質
간세포%면역자화분리%갑상방선격소상관단백질
Stem cells%Immunomagnetic separation%Parathyroid hormone-related protein
目的 免疫纯化新生大鼠骨骺干细胞,克隆甲状旁腺相关蛋白的中间片段PTHrP(38-94)基因并构建四环素反应性元件调控的反应质粒pTRE-PTHrP(38-94).方法 采用免疫磁珠技术分离纯化具有FGFR-3特异性表面标志的骨骺干细胞,分别以FGFR-3抗体和PCNA抗体对骨骺干细胞的细胞爬片进行免疫细胞化学鉴定.提取骨骺干细胞的总RNA,以RT-PCR方法获得带有酶切位点PTHrP(38-94)基因片段,扩增的DNA片段与含潮霉素筛选标记的四环素反应性元件载体pTRE-2Hyg均双酶切后连接,转化、扩增后对重组质粒进行提取和酶切、测序鉴定.结果 免疫荧光证实所取材分离并纯化的细胞为骨骺干细胞;经限制性内切酶Barn H I、Not Ⅰ酶切图谱分析和DNA序列测定证实目的 基因已经插入重组质粒.结论 运用显微取材和免疫纯化技术可以成功分离纯化骨骺干细胞;成功克隆PTHrP(38-94)基因并构建了反应质粒pTRE-PTHrP(38-94),为进一步明确PTHrP(38-94)片段的生物学功能及其在成软骨和成骨分化过程中的作用奠定了基础.
目的 免疫純化新生大鼠骨骺榦細胞,剋隆甲狀徬腺相關蛋白的中間片段PTHrP(38-94)基因併構建四環素反應性元件調控的反應質粒pTRE-PTHrP(38-94).方法 採用免疫磁珠技術分離純化具有FGFR-3特異性錶麵標誌的骨骺榦細胞,分彆以FGFR-3抗體和PCNA抗體對骨骺榦細胞的細胞爬片進行免疫細胞化學鑒定.提取骨骺榦細胞的總RNA,以RT-PCR方法穫得帶有酶切位點PTHrP(38-94)基因片段,擴增的DNA片段與含潮黴素篩選標記的四環素反應性元件載體pTRE-2Hyg均雙酶切後連接,轉化、擴增後對重組質粒進行提取和酶切、測序鑒定.結果 免疫熒光證實所取材分離併純化的細胞為骨骺榦細胞;經限製性內切酶Barn H I、Not Ⅰ酶切圖譜分析和DNA序列測定證實目的 基因已經插入重組質粒.結論 運用顯微取材和免疫純化技術可以成功分離純化骨骺榦細胞;成功剋隆PTHrP(38-94)基因併構建瞭反應質粒pTRE-PTHrP(38-94),為進一步明確PTHrP(38-94)片段的生物學功能及其在成軟骨和成骨分化過程中的作用奠定瞭基礎.
목적 면역순화신생대서골후간세포,극륭갑상방선상관단백적중간편단PTHrP(38-94)기인병구건사배소반응성원건조공적반응질립pTRE-PTHrP(38-94).방법 채용면역자주기술분리순화구유FGFR-3특이성표면표지적골후간세포,분별이FGFR-3항체화PCNA항체대골후간세포적세포파편진행면역세포화학감정.제취골후간세포적총RNA,이RT-PCR방법획득대유매절위점PTHrP(38-94)기인편단,확증적DNA편단여함조매소사선표기적사배소반응성원건재체pTRE-2Hyg균쌍매절후련접,전화、확증후대중조질립진행제취화매절、측서감정.결과 면역형광증실소취재분리병순화적세포위골후간세포;경한제성내절매Barn H I、Not Ⅰ매절도보분석화DNA서렬측정증실목적 기인이경삽입중조질립.결론 운용현미취재화면역순화기술가이성공분리순화골후간세포;성공극륭PTHrP(38-94)기인병구건료반응질립pTRE-PTHrP(38-94),위진일보명학PTHrP(38-94)편단적생물학공능급기재성연골화성골분화과정중적작용전정료기출.
Objective To establish the method of separating and purifying rat precartilaginous stem cells (PCSCs) by immunomagnetic technology, clone the mid-fragment of parathroid hormonerelated peptide gene PTHrP(38-94) and construct plasmids of tetracycline(Tet) responsive element which regulates and controls the expression of PTHrP(38-94). Methods Immunornagnetic separation was used to segregate PCSCs labeled with fibroblast growth factor receptor-3(FGFR-3). The PCSCs were identified by imrnunocytochemistry with anti-FGFR-3 and anti-PCNA. The total RNA was extracted from PCSCs after identification and the mid-fragment of PTHrP(38-94) gene was obtained by RT-PCR method. With the added endonuclease Sites, PTHrP(38-94) gene was double-enzyme digested by Bam H Ⅰ and Not Ⅰ. The gene was subcloned to plasmids of Tet-responsive element with the selection marker of hygromycin pTRE-2Hyg to construct recombinant eukaryotic expressive plasmid pTRE-PTHrP(38-94). Then the recombinant plasmids were transferred into E. coli-DH5α and the clones were randomly selected. Then the recombinant plasmids were purified and identified by doubleenzyme digestion. Results The results of immunocytochemistry confirmed that the rat pre-cartilaginous stem cells was obtained by the micro-segregate and purified by immunomagnetic technology. Double enzyme digestion analysis and sequencing showed that the target gene was cloned into recombinant plasmids. Conclusions The purified PCSCs can be identified accurately and the responsive plasmids containing PTHrp(38-94) gene can be successfully constructed, which may give new strategy for investigation of the biological function of the PTHrp(38-94) gene in the differentiation of chondrocytes and osteocytes.